Trends in Retinopathy of Prematurity Among Preterm Infants in California, 2012 to 2021

Retinal Diseases

Red blood cell parameters as biomarkers of retinopathy of prematurity in preterm infants born before 30 weeks of gestation

Sci Rep

Maeda H, Go H, Iwasa H, Hiruta S, Ichikawa H, Sugano Y, Ogasawara K, Momoi N, Sekiryu T, Hosoya M

doi: 10.1038/s41598-024-84030-x

Retinal Diseases

Predicting the risk of treatment-requiring retinopathy of prematurity in preterm infants in Greece. External validation of DIGIROP prognostic models

Acta Ophthalmol

Moutzouri S, Pivodic A, Haidich AB, Seliniotaki AK, Lithoxopoulou M, Tsakalidis C, Hellström A, Ziakas N, Mataftsi A

doi: 10.1111/aos.16788

Blindness and Vision ImpairmentRetinal Diseases

Retinopathy of Prematurity: Incidence, Risk Factors, and Treatment Outcomes in a Tertiary Care Center

J Clin Med

Blazon MN, Rezar-Dreindl S, Wassermann L, Neumayer T, Berger A, Stifter E

doi: 10.3390/jcm13226926

Retinal Diseases

Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers

BMC Ophthalmol

Zhong Y, Lin X, Yang Y, He L, Li N, Lu J, Zhou Y, Zhang R, Wang Y, Zhang Z, Yang M, Yin H, Zhao M, Li X, Liang J, Cheng Y

doi: 10.1186/s12886-024-03836-5

Retinal DiseasesFurther Publications

Efficacy and Safety of Mydriatic Microdrops for Retinopathy of Prematurity Screening: The MyMiROPS Randomized Clinical Trial

JAMA Ophthalmol

Seliniotaki AK, Lithoxopoulou M, Virgiliou C, Gika H, Dokoumetzidis A, Bougioukas KI, Raikos N, Diamanti E, Ziakas N, Haidich AB, Mataftsi A

doi: 10.1001/jamaophthalmol.2024.5462

Retinal Diseases

Bilateral Anti VEGF on Same Day-Investigation on Safety in Retinopathy of Prematurity (BASISROP)- A Multicenter retrospective study

Ophthalmol Retina

Gangwe AB, Agrawal A, Jalali S, Banker A, Padhi T, Shah P, Rajan RP, Kulkarni S, Shah S, Singhal R, Das P, Kapoor A, Vinekar A, Bavaskar S, Vedantham V, Sanghi G, Bhattacharya S, Banker A, Gaikwad A, Shrivastava S, Nayak S, Panchal B, Agrawal D, Azad RV

doi: 10.1016/j.oret.2024.11.004

Retinal Diseases

Prediction of retinopathy of prematurity development and treatment need with machine learning models

BMC Ophthalmol

Durmaz Engin C, Ozturk T, Ozkan O, Oztas A, Selver MA, Tuzun F

doi: 10.1186/s12886-025-04025-8

Retinal Diseases

Retinal vascularization rate predicts retinopathy of prematurity and remains unaffected by low-dose bevacizumab treatment

Am J Ophthalmol

Chang E, Josan A, Purohit R, Aslam SA, Hartley C, Patel CK, Xue K

doi: 10.1016/j.ajo.2025.02.040

Retinal Diseases

A meta-analysis of intravitreal ranibizumab versus laser photocoagulation for the treatment of retinopathy of prematurity

Ophthalmol Retina

Baiad AA, Sun C, Yin GS, Popovic MM, Muni RH, Mireskandari K, Kertes PJ

doi: 10.1016/j.oret.2025.01.012

Related content

Red blood cell parameters as biomarkers of retinopathy of prematurity in preterm infants born before 30 weeks of gestation

Predicting the risk of treatment-requiring retinopathy of prematurity in preterm infants in Greece. External validation of DIGIROP prognostic models

Retinopathy of Prematurity: Incidence, Risk Factors, and Treatment Outcomes in a Tertiary Care Center

Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers

Efficacy and Safety of Mydriatic Microdrops for Retinopathy of Prematurity Screening: The MyMiROPS Randomized Clinical Trial

Bilateral Anti VEGF on Same Day-Investigation on Safety in Retinopathy of Prematurity (BASISROP)- A Multicenter retrospective study

Prediction of retinopathy of prematurity development and treatment need with machine learning models

Retinal vascularization rate predicts retinopathy of prematurity and remains unaffected by low-dose bevacizumab treatment

A meta-analysis of intravitreal ranibizumab versus laser photocoagulation for the treatment of retinopathy of prematurity